Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2011
03/31/2011US20110076258 Methods of modulating t cell- dependent immune responses
03/31/2011US20110076254 Porous scaffolds for stem cell renewal
03/31/2011US20110076234 Peptides comprising an isodgr motif
03/31/2011CA2775276A1 Compositions and methods for the prevention and treatment of metabolic diseases
03/31/2011CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors
03/31/2011CA2775027A1 Maleic acid salt and crystal thereof
03/31/2011CA2774951A1 Method of treating osteoporosis with a neurotoxin
03/30/2011EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis
03/30/2011EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus
03/30/2011EP2301971A1 Antibodies that bind both BCMA and TACI
03/30/2011EP2301970A1 Human antibodies that bind human IL-12 and methods for producing
03/30/2011EP2301967A2 Single domain antibodies for nasal administration
03/30/2011EP2301930A1 Thrombin receptor antagonists
03/30/2011EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities
03/30/2011EP2301578A2 Methods for treating TWEAK-related conditions
03/30/2011EP2301577A2 Methods for treating TWEAK-related conditions
03/30/2011EP2301554A1 Composition for the treatment of osteoarthritis
03/30/2011EP2301553A1 Polynucleotide therapy
03/30/2011EP2301552A1 Polynucleotide therapy
03/30/2011EP2301550A1 Tetracycline compounds having target therapeutic activities
03/30/2011EP2301534A1 Amino-methyl substituted tetracycline compounds
03/30/2011EP2301529A1 Hydroxymethylbutyrate compositions and uses thereof
03/30/2011EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
03/30/2011EP2300485A1 Pyrrolo ý2, 3-c¨pyridine derivatives as p38 kinase inhibiting agents
03/30/2011EP2300461A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/30/2011EP2300030A2 Rice bran extracts and methods of use thereof
03/30/2011EP2300029A2 Rice bran extracts for inflammation and methods of use thereof
03/30/2011EP2300011A1 Therapeutic methods and compounds
03/30/2011EP2299991A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
03/30/2011EP2299824A1 Pyrazole derivatives useful as inhibitors of faah
03/30/2011EP1829536B1 Ameliorant for renal insufficiency
03/30/2011CN201775803U Plaster
03/30/2011CN1976710B Compounds and compositions as cathepsin S inhibitors
03/30/2011CN1872058B Medication composition of containing macrolides
03/30/2011CN1780855B Human il-1 beta antagonists
03/30/2011CN1489583B Novel physiologically active substance
03/30/2011CN101998857A Wet granulation using a water sequestering agent
03/30/2011CN101991852A Application of miR-494 inhibitor in preparing preparation for resisting bone calcium loss and promoting bone formation
03/30/2011CN101991838A Medicinal composition for curing osteoproliferation, rheumatism, rheumatoid diseases and herniated disk
03/30/2011CN101991834A External traditional Chinese medicine package for treating lumbar diseases
03/30/2011CN101991833A External traditional Chinese medicine bag for treating arthritis
03/30/2011CN101991826A Cervical vertebra osteoproliferation secret recipe
03/30/2011CN101991811A Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof
03/30/2011CN101991792A Traditional Chinese medicinal composition for treating gout and preparation method thereof
03/30/2011CN101991752A Traditional Chinese medicine formula for treating gout
03/30/2011CN101991742A Traditional Chinese medicine formula for treating lumbar disc herniation
03/30/2011CN101991736A Medicament for treating osteopathy
03/30/2011CN101991735A External-application ointment
03/30/2011CN101991729A Medicinal liquor for relaxing muscles and tendons
03/30/2011CN101991716A New application of pharmaceutical composition of vital energy benefiting and smart decoction and the like in prevention and cure of osteoporosis
03/30/2011CN101991714A Externally used medicine for treating rheumatic arthritis and preparation method thereof
03/30/2011CN101991710A Medical vertebral rehabilitation powder for treating prolapsed intervertebral disease
03/30/2011CN101991672A Medicinal liquor for treating herniated disk and hyperosteogeny as well as preparation method thereof
03/30/2011CN101991666A Ointment for treating pain in neck, shoulder, waist and legs and preparation method thereof
03/30/2011CN101991665A Composition for treating myocardial diseases, femoral head necrosis and tumor and preparation process thereof
03/30/2011CN101991639A Bone-knitting medicament
03/30/2011CN101991634A Traditional Chinese medicine composite for treating lumbar disc herniation
03/30/2011CN101991633A Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof
03/30/2011CN101991620A Medicament prepared from okra extractive and application thereof
03/30/2011CN101991585A Percutaneous absorption film coating agent for treating rheumatoid arthritis and preparation method thereof
03/30/2011CN101991575A Application of evodiamine in preparing medicine for inhibiting aryl hydrocarbon receptor
03/30/2011CN101991548A Reduced glutathione freeze-dried powder injection and preparation method thereof
03/30/2011CN101991517A Novel Chinese medicine natural essential oil skin-care product
03/30/2011CN101579416B Orthopedics plaster
03/30/2011CN101485637B Colchicine framework controlled release tablets or capsules
03/30/2011CN101444574B Method for preparing daphne giraldii fluid extract and controlling the quality of same
03/30/2011CN101385852B Preparation method of bone collagen tablet
03/30/2011CN101361818B Traditional Chinese medicine combination for treating shoulder-hand syndrome
03/30/2011CN101322787B Specific medicinal liquor for treating rheumatoild disease
03/30/2011CN101306003B Use of cyaniding 3-0 glucoside in preparing medicament or food for preventing and curing atrophic arthritis
03/30/2011CN101185643B Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine
03/29/2011US7915310 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate
03/29/2011US7915308 Therapeutic methods and compositions involving isoflavones
03/29/2011US7915286 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
03/29/2011US7915280 Compounds and their uses
03/29/2011US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same
03/29/2011US7915268 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection
03/29/2011US7915265 Combinations for the treatment of immunoinflammatory disorders
03/29/2011US7915264 Drugs for treating pain formed by arylation
03/29/2011US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
03/29/2011US7915239 Treating lameness with an osseous and/or articular component which appear in a person or animal not suffering from fractures or arthritis; horses; veterinary medicine; bone disorders, osteoarthritis
03/29/2011CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
03/29/2011CA2435730C Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
03/29/2011CA2390652C Human circulating virus-inhibiting peptide (virip) and its use
03/29/2011CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
03/29/2011CA2299139C 4-phenyl-pyridine derivatives
03/29/2011CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
03/24/2011WO2011034916A2 Bone substitute compositions, methods of preparation and clinical applications
03/24/2011WO2011034896A2 Small molecule inhibitors of the alpha4-paxillin interaction
03/24/2011WO2011034274A2 Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol
03/24/2011WO2011034223A1 Composition for preventing and treating bone diseases, containing medicinal herb extracts as active ingredient
03/24/2011WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
03/24/2011WO2011034078A1 Glycine compound
03/24/2011WO2011034006A1 Composition for lowering blood uric acid level
03/24/2011WO2011033306A1 Inhibition of tendon adhesions
03/24/2011WO2011007347A3 Therapy of non alcoholic fatty liver disease utilizing inula viscosa extract
03/24/2011WO2010137021A3 Method of generating connective tissue
03/24/2011WO2010131922A3 Amide compound, preparation method thereof and pharmaceutical composition comprising same
03/24/2011WO2010129053A3 Egfr inhibitors and methods of treating disorders